Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNichols plc Regulatory News (NICL)

Share Price Information for Nichols plc (NICL)

Share Price is delayed by 15 minutes
Get Live Data
944.00    2.00 (0.21%)
Bid:
940.00
Ask:
954.00
Spread: 14.00 (1.489%)
Market Cap: £345.17m
NICL Live PriceLast checked at - London Stock Exchange

Intraday Nichols plc Share Chart

Director/PDMR Shareholding

9 Aug 2016 07:58

RNS Number : 6312G
Nichols PLC
09 August 2016
 

Nichols plc("Nichols" or the "Company")

Exercise of Share Options, PDMR Dealing and Transaction in Own Shares

Nichols announces that it was notified on 8 August 2016 that on the same day, Marnie Millard, Group Chief Executive Officer, exercised share options over 17,561 ordinary shares of 10 pence each in the Company ("Ordinary Shares"), granted in 2013 under the Company's Long Term Incentive Plan, for a total cost of £1. The share options became exercisable on 31 July 2016 following satisfaction of a number of performance conditions relating to the Company's profit before tax. To satisfy the exercise of the share options, 17,561 existing Ordinary Shares were transferred from treasury. Following this announcement, the Company now holds 85,039 Ordinary Shares in treasury.

On 8 August 2016, Marnie Millard sold 8,254 Ordinary Shares to settle the associated tax liability, as a result of the exercise of options, at 1,400 pence per Ordinary Share.

Following the exercise of share options and the subsequent sale of Ordinary Shares, Marnie Millard's notifiable interest in the Company is 9,307 Ordinary Shares, representing approximately 0.03% of the Company's issued Ordinary Shares.

Contacts:

Tim Croston, Group Chief Financial Officer

Nichols plc

Telephone: 01925 222222

Website:www.nicholsplc.co.uk

Richard Lindley and James White

N+1 Singer (Nominated Adviser)

Telephone: 0207 496 3000

 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Marnie Millard

b)

Position / status

Group Chief Executive Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares

b)

Nature of the transaction

Exercise of Options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£1 in total

17,561

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

8 August 2016

f)

Place of the transaction

London Stock Exchange, AIM

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Marnie Millard

b)

Position / status

Group Chief Executive Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares

b)

Nature of the transaction

Disposal of Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1,400p

8,254

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

8 August 2016

f)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHKMGGRVLNGVZG
Date   Source Headline
3rd Jun 20267:00 amRNSExercise of Options and Director/PDMR Dealings
3rd Jun 20267:00 amRNSGrant of SAYE Options and PDMR Dealings
27th May 20263:13 pmRNSHolding(s) in Company
24th Apr 20267:00 amRNSGrant of Options
22nd Apr 20263:21 pmRNSHolding(s) in Company
21st Apr 20265:59 pmRNSResult of AGM
21st Apr 20267:00 amRNSAGM Trading Update
20th Apr 20267:00 amRNSConcert Party Shareholding
24th Mar 20267:00 amRNSGrant of Options
23rd Mar 20267:00 amRNSPublication of Annual Report and Notice of AGM
17th Mar 20267:00 amRNSGrant of Options
17th Mar 20267:00 amRNSGrant of Options
11th Mar 20267:00 amRNS2025 Preliminary Results
6th Mar 20267:00 amRNS-RNotice of Results and Investor Presentation
14th Jan 20267:00 amRNSFY25 Trading Update
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
12th Dec 20252:46 pmRNSDirector/PDMR Dealing
12th Dec 20257:00 amRNSGrant of Share Award
1st Dec 20255:00 pmRNSHoldings in Company
1st Dec 20255:00 pmRNSDirector Shareholding
11th Nov 20257:00 amRNSAppointment of Chief Financial Officer
29th Sep 20252:16 pmRNSHolding(s) in Company
8th Aug 20252:59 pmRNSDirector/PDMR Dealing
7th Aug 202510:26 amRNSDirector/PDMR Dealing
31st Jul 20257:00 amRNS2025 Interim Results
23rd Jul 20257:00 amRNS-RNotice of Results and Investor Presentation
16th Jun 20252:08 pmRNSHolding(s) in Company
11th Jun 20252:45 pmRNSExercise of Options and Director / PDMR Dealing
9th Jun 20255:25 pmRNSHolding(s) in Company
29th May 20254:53 pmRNSExercise of Options, Director/PDMR Dealing & TVR
6th May 20252:44 pmRNSHolding(s) in Company
2nd May 20258:25 amRNSHolding(s) in Company
29th Apr 20253:15 pmRNSGrant of SAYE Options and PDMR Dealings
28th Apr 20254:45 pmRNSHolding(s) in Company
23rd Apr 20255:40 pmRNSResult of Annual General Meeting
23rd Apr 20257:00 amRNSAGM Trading Update
1st Apr 20253:20 pmRNSHolding(s) in Company
26th Mar 20257:00 amRNSPublication of Annual Report & Notice of AGM
26th Mar 20257:00 amRNSHolding(s) in Company
26th Mar 20257:00 amRNSGrant of Options & PDMR Dealings
17th Mar 20253:43 pmRNSNotification of the passing of Richard Newman, CFO
11th Mar 20257:00 amRNS2024 Preliminary Results
11th Mar 20257:00 amRNSNon-Executive Board Changes
6th Mar 202511:42 amRNS-RNotice of Results and Investor Presentation
3rd Feb 20257:00 amRNSAppointment of Joint Corporate Broker
23rd Jan 20257:00 amRNSBoard Responsibilities
15th Jan 20257:00 amRNSFY24 Trading Update
6th Nov 20247:00 amRNSCapital Markets Day & Medium-Term Ambitions
31st Oct 20244:29 pmRNSDirector Shareholding
24th Oct 20242:00 pmRNSNotice of CMD & Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.